Published by Iain Gilbert on 20th January 2020
(Sharecast News) - Clinical-stage life sciences company MaxCyte told investors on Monday that its board was "exceptionally positive" of the group's future following a stellar year.
URL: http://www.digitallook.com/dl/news/story/30130650/...